Skip to content

3D navigated kyphoplasty versus standard 2D fluoroscopy guided kyphoplasty - a prospective randomised trial to compare accuracy of the trajectory, complications, radiation dose and outcome

3D navigated kyphoplasty versus standard 2D fluoroscopy guided kyphoplasty - a prospective randomised trial to compare accuracy of the trajectory, complications, radiation dose and outcome - kyphona

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012976
Enrollment
68
Registered
2017-09-20
Start date
2017-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M80.88 C79.5 T08.1

Interventions

Group 1: Standard 2D fluoroscopy guided kyphoplasty Group 2: 3D navigated kyphoplasty

Sponsors

Klinikum rechts der Isar der TU München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients in our hospital where kyphoplasty is indicated in at least one level (due to osteoporotic and/or pathological vertebral fracture) in the thoracolumbar spine, will be included

Exclusion criteria

Exclusion criteria: minors, inability to provide informed consent, pregnancy, additional surgical stabilisation in relation to the same segment, planned open surgery

Design outcomes

Primary

MeasureTime frame
We want to evaluate if the accuracy of the vertebroplasty-needle position is significantly better using 3D navigation in comparison to standard 2D fluoroscopy. To evaluate accuracy the modified Gertzbein and Robbins classification is used (grade 1, 2 high accuracy and grade 3,4,5 low accuracy).

Secondary

MeasureTime frame
We hypothesise that the rate of complications in relation to needle positioning is significantly lower in the navigated kyphoplasty group. Additionally we will evaluate if there is a significant difference in total radiation dose and surgery time, as well es postoperative outcome measured by VAS (Visuell Pain Scale); ODI (Oswestry Disability Index) and quality of life (SF-12,Eq5) before and after (3,12 months) surgery.

Countries

Germany

Contacts

Public ContactAnna Rienmüller

Klinikum rechts der Isar der TU München

anna.rienmueller@tum.de004989414072151

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026